Company NewAmsterdam Pharma Company N.V. Deutsche Boerse AG
Equities
KH6
NL00150012L7
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.3 EUR | +0.55% |
|
+3.98% | +86.73% |
Business Summary
Number of employees: 40
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Transformative Therapies for Cardio-metabolic Diseases
100.0
%
| 102 | 100.0 % | 15 | 100.0 % | -85.13% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Italy
100.0
%
| 102 | 100.0 % | 15 | 100.0 % | -85.13% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 89,976,538 | 84,841,876 ( 94.29 %) | 0 | 94.29 % |
Company contact information
NewAmsterdam Pharma Co. NV
Gooimeer 2-35
1411 DC, Naarden
+31 35 206 2971
http://www.newamsterdampharma.com![address NewAmsterdam Pharma Company N.V.(KH6)](https://cdn.zonebourse.com/static/address/148741508.png)
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- NAMS Stock
- KH6 Stock
- Company NewAmsterdam Pharma Company N.V.